C. Baillard, J. Fosse, M. Sebbane, G. Chanques, F. Vincent et al., Noninvasive Ventilation Improves Preoxygenation before Intubation of Hypoxic Patients, American Journal of Respiratory and Critical Care Medicine, vol.174, issue.2, pp.171-177, 2006.
DOI : 10.1164/rccm.200509-1507OC

S. Jaber, J. Amraoui, J. Lefrant, C. Arich, R. Cohendy et al., Clinical practice and risk factors for immediate complications of endotracheal intubation in the intensive care unit: A prospective, multiple-center study*, Critical Care Medicine, vol.34, issue.9, pp.2355-2361, 2006.
DOI : 10.1097/01.CCM.0000233879.58720.87

F. Petrini, A. Accorsi, E. Adrario, F. Agro, G. Amicucci et al., Recommendations for airway control and difficult airway management, Minerva Anestesiol, vol.71, pp.617-657, 2005.

D. Griesdale, T. Bosma, T. Kurth, G. Isac, and D. Chittock, Complications of endotracheal intubation in the critically ill, Intensive Care Medicine, vol.158, issue.10, pp.1835-1842, 2008.
DOI : 10.1007/s00134-008-1205-6

S. Jaber, B. Jung, P. Corne, M. Sebbane, L. Muller et al., An intervention to decrease complications related to endotracheal intubation in the intensive care unit: a prospective, multiple-center study, Intensive Care Medicine, vol.270, issue.2, pp.248-255, 2010.
DOI : 10.1007/s00134-009-1717-8

P. Jabre, X. Combes, F. Lapostolle, M. Dhaouadi, A. Ricard-hibon et al., Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial, The Lancet, vol.374, issue.9686, pp.293-300, 2009.
DOI : 10.1016/S0140-6736(09)60949-1

J. Walz, M. Zayaruzny, and S. Heard, Airway Management in Critical Illness, Chest, vol.131, issue.2, pp.608-620, 2007.
DOI : 10.1378/chest.06-2120

G. Malerba, F. Romano-girard, A. Cravoisy, B. Dousset, L. Nace et al., Risk factors of relative adrenocortical deficiency in intensive care patients needing mechanical ventilation, Intensive Care Medicine, vol.279, issue.3, pp.388-392, 2005.
DOI : 10.1007/s00134-004-2550-8

R. Wagner, P. White, P. Kan, M. Rosenthal, and D. Feldman, Inhibition of Adrenal Steroidogenesis by the Anesthetic Etomidate, New England Journal of Medicine, vol.310, issue.22, pp.1415-1421, 1984.
DOI : 10.1056/NEJM198405313102202

J. Payen, C. Dupuis, T. Trouve-buisson, M. Vinclair, C. Broux et al., Corticosteroid after etomidate in critically ill patients, Critical Care Medicine, vol.40, issue.1, pp.29-35, 2012.
DOI : 10.1097/CCM.0b013e31822d7938
URL : https://hal.archives-ouvertes.fr/inserm-00658789

M. Den-brinker, A. Hokken-koelega, J. Hazelzet, F. De-jong, W. Hop et al., One single dose of etomidate negatively influences adrenocortical performance for at least 24???h in children with meningococcal sepsis, Intensive Care Medicine, vol.54, issue.1, pp.163-168, 2008.
DOI : 10.1007/s00134-007-0836-3

P. Marik, S. Pastores, D. Annane, G. Meduri, C. Sprung et al., Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statements from an international task force by the American College of Critical Care Medicine, Critical Care Medicine, vol.36, issue.6, pp.1937-1949, 2008.
DOI : 10.1097/CCM.0b013e31817603ba

D. Annane and E. Bellissant, Prognostic value of cortisol response in septic shock, JAMA, vol.284, pp.308-309, 2000.

M. Jong, A. Beishuizen, J. Spijkstra, and A. Groeneveld, Relative adrenal insufficiency as a predictor of disease severity, mortality, and beneficial effects of corticosteroid treatment in septic shock, Critical Care Medicine, vol.35, issue.8, pp.1896-1903, 2007.
DOI : 10.1097/01.CCM.0000275387.51629.ED

B. Jung, S. Nougaret, G. Chanques, G. Mercier, M. Cisse et al., R2: The Absence of Adrenal Gland Enlargement during Septic Shock Predicts Mortality, Anesthesiology, vol.115, issue.2, pp.334-343, 2011.
DOI : 10.1097/ALN.0b013e318225cfd7

M. Jong, A. Beishuizen, J. Spijkstra, A. Girbes, and A. Groeneveld, Relative adrenal insufficiency: an identifiable entity in nonseptic critically ill patients?, Clinical Endocrinology, vol.88, issue.5, pp.732-739, 2007.
DOI : 10.1097/01.CCM.0000059646.89546.98

W. Jackson and . Jr, Should We Use Etomidate as an Induction Agent for Endotracheal Intubation in Patients With Septic Shock?, Chest, vol.127, issue.3, pp.1031-1038, 2005.
DOI : 10.1378/chest.127.3.1031

S. Albert, S. Ariyan, and A. Rather, The effect of etomidate on adrenal function in critical illness: a systematic review, Intensive Care Medicine, vol.56, issue.8336, pp.901-910, 2011.
DOI : 10.1007/s00134-011-2160-1

B. Cuthbertson, C. Sprung, D. Annane, S. Chevret, M. Garfield et al., The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock, Intensive Care Medicine, vol.34, issue.11, pp.1868-1876, 2009.
DOI : 10.1007/s00134-009-1603-4

D. Lipiner-friedman, C. Sprung, P. Laterre, Y. Weiss, S. Goodman et al., Adrenal function in sepsis: The retrospective Corticus cohort study, Critical Care Medicine, vol.35, issue.4, pp.1012-1018, 2007.
DOI : 10.1097/01.CCM.0000259465.92018.6E

Z. Mohammad, B. Afessa, and J. Finkielman, The incidence of relative adrenal insufficiency in patients with septic shock after the administration of etomidate, Critical Care, vol.10, issue.4, p.105, 2006.
DOI : 10.1186/cc4979

D. Dmello, S. Taylor, J. O-'brien, and G. Matuschak, Outcomes of Etomidate in Severe Sepsis and Septic Shock, Chest, vol.138, issue.6, pp.1327-1332, 2010.
DOI : 10.1378/chest.10-0790

D. Ray and D. Mckeown, Effect of induction agent on vasopressor and steroid use, and outcome in patients with septic shock, Critical Care, vol.11, issue.3, p.56, 2007.
DOI : 10.1186/cc5916

F. Riche, C. Boutron, P. Valleur, C. Berton, M. Laisne et al., Adrenal response in patients with septic shock of abdominal origin: relationship to survival, Intensive Care Medicine, vol.33, issue.10, pp.1761-1766, 2007.
DOI : 10.1007/s00134-007-0770-4

S. Nougaret, B. Jung, S. Aufort, G. Chanques, S. Jaber et al., Adrenal gland volume measurement in septic shock and control patients: a pilot study, European Radiology, vol.22, issue.10, pp.2348-2357, 2010.
DOI : 10.1007/s00330-010-1804-9

D. Annane, Corticosteroids in Severe Sepsis, Clinical Pulmonary Medicine, vol.8, issue.5, pp.1-7, 2011.
DOI : 10.1097/00045413-200109000-00003

C. Sprung, D. Annane, D. Keh, R. Moreno, M. Singer et al., Hydrocortisone Therapy for Patients with Septic Shock, New England Journal of Medicine, vol.358, issue.2, pp.111-124, 2008.
DOI : 10.1056/NEJMoa071366

E. Von-elm, D. Altman, M. Egger, S. Pocock, P. Gotzsche et al., The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies, Journal of Clinical Epidemiology, vol.61, issue.4, pp.344-349, 2008.
DOI : 10.1016/j.jclinepi.2007.11.008

M. Vinclair, C. Broux, P. Faure, J. Brun, C. Genty et al., Duration of adrenal inhibition following a??single dose of etomidate in critically ill patients, Intensive Care Medicine, vol.54, issue.4, pp.714-719, 2008.
DOI : 10.1007/s00134-007-0970-y
URL : https://hal.archives-ouvertes.fr/inserm-00398796

R. Dellinger, M. Levy, J. Carlet, J. Bion, M. Parker et al., Surviving Sepsis Campaign, Critical Care Medicine, vol.41, issue.2, pp.296-327, 2008.
DOI : 10.1097/CCM.0b013e31827e83af

R. Bone, R. Balk, F. Cerra, R. Dellinger, A. Fein et al., Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis, The ACCP/SCCM Consensus Conference Committee, pp.1644-1655, 1992.
DOI : 10.1378/chest.101.6.1644

E. Gilbert, S. Lowenstein, J. Koziol-mclain, D. Barta, and J. Steiner, Chart Reviews In Emergency Medicine Research: Where Are The Methods?, Annals of Emergency Medicine, vol.27, issue.3, pp.305-308, 1996.
DOI : 10.1016/S0196-0644(96)70264-0

E. Gayat, R. Pirracchio, M. Resche-rigon, A. Mebazaa, J. Mary et al., Propensity scores in intensive care and anaesthesiology literature: a systematic review, Intensive Care Medicine, vol.24, issue.12, pp.1993-2003, 2011.
DOI : 10.1007/s00134-010-1991-5

L. Gall, J. Lemeshow, S. Saulnier, and F. , A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter Study, JAMA: The Journal of the American Medical Association, vol.270, issue.24, pp.2957-2963, 1993.
DOI : 10.1001/jama.1993.03510240069035

J. Vincent, A. De-mendonca, F. Cantraine, R. Moreno, J. Takala et al., Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units, Critical Care Medicine, vol.26, issue.11, pp.1793-1800, 1998.
DOI : 10.1097/00003246-199811000-00016

R. Fernandez, A. Tizon, J. Gonzalez, P. Monedero, M. Garcia-sanchez et al., Intensive care unit discharge to the ward with a tracheostomy cannula as a risk factor for mortality: A prospective, multicenter propensity analysis*, Critical Care Medicine, vol.39, issue.10, pp.2240-2245, 2011.
DOI : 10.1097/CCM.0b013e3182227533

D. Suarez, J. Haro, D. Novick, and S. Ochoa, Marginal structural models might overcome confounding when analyzing multiple treatment effects in observational studies, Journal of Clinical Epidemiology, vol.61, issue.6, pp.525-530, 2008.
DOI : 10.1016/j.jclinepi.2007.11.007

F. Jong, C. Mallios, C. Jansen, P. Scheck, and S. Lamberts, Etomidate Suppresses Adrenocortical Function by Inhibition of 1 l??-Hydroxylation, The Journal of Clinical Endocrinology & Metabolism, vol.59, issue.6, pp.1143-1147, 1984.
DOI : 10.1210/jcem-59-6-1143

A. Hildreth, V. Mejia, R. Maxwell, P. Smith, B. Dart et al., Adrenal Suppression Following a Single Dose of Etomidate For Rapid Sequence Induction: A Prospective Randomized Study, The Journal of Trauma: Injury, Infection, and Critical Care, vol.65, issue.3, pp.573-579, 2008.
DOI : 10.1097/TA.0b013e31818255e8

H. Chang, K. Lin, Y. Tai, J. Chen, and R. Chen, Lipoteichoic acid-induced TNF-alpha and IL-6 gene expressions and oxidative stress production in macrophages are suppressed by ketamine through downregulating Tolllike receptor 2-mediated activation oF ERK1/2 and NF?B, Shock, vol.33, pp.485-492, 2010.

M. Yu, D. Shao, J. Liu, J. Zhu, Z. Zhang et al., Effects of ketamine on levels of cytokines, NF-??B and TLRs in rat intestine during CLP-induced sepsis, International Immunopharmacology, vol.7, issue.8, pp.1076-1082, 2007.
DOI : 10.1016/j.intimp.2007.04.003